Table 2.
Haematological Findings of the Study Population.
| GP (A) Survivors (1139) |
GP (B) Non-Survivors (349) |
p-Value | |
|---|---|---|---|
| HB-A1c (<42 mmol/mol) |
52.22 (19.46) | 50.75 (16.38) | 0.530 |
| T-CHOL (<5 mmol/L) |
4.88 (3.48) | 4.39 (0.99) | 0.329 |
| WBCs (4–11 × 109/L) |
8.004 (7.33) | 9.00 (10.1) | 0.095 |
| Hb (115–160 g/L) |
131.72 (21.47) | 122.81 (24.52) | 0.0001 * |
| MCV (80–100 fL) |
86.08 (7.82) | 90.01 (8.80) | 0.0001 * |
| PLT (150–450 × 109/L) |
255.85 (106.17) | 232.49 (104.83) | 0.0001 |
| Neut (1.7–7.5 × 109/L) |
5.92 (4.47) | 6.82 (4.37) | 0.0013 * |
| Lymph (1–4 × 109/L) |
1.32 (1.042) | 1.51 (8.58) | 0.695 |
| Mono (0.2 * 80 × 109/L) |
0.6161 (1.722) | 0.596 (0.44) | 0.839 |
| Eos (>0.5 × 109/L) |
0.058 (0.13) | 0.059 (0.30) | 0.877 |
| Baso (>0.1 × 109/L) |
0.024 (0.023) | 0.025 (0.032) | 0.859 |
| Neut/Lymph | 6.173 (6.095) | 9.52 (9.66) | <0.0001 * |
| LDH/ALB X Urea | 36.51 (92.64) | 81.63 (168.70) | <0.0001 * |
Abbreviations: HB-A1c, haemoglobin A1C; T-CHOL, total cholesterol; WBCs, white blood cells; Hb, haemoglobin; MCV, mean corpuscular volume; PLT, platelets; Neut, neutrophils; Lymph, lymphocytes; Mono; monocytes; Eos, eosinophils; Baso, basophils; Neut/Lymph, neutrophils to lymphocytes ratio; LDH/ALB X Urea, Lactate dehydrogenase/Albumin to-urea ratio. * Significant p-values are indicated where p < 0.05 was considered significant.